| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.5M | — | -24.9% |
| Cost of Revenue | $15.2M | — | +13.4% |
| R&D Expense | $14.5M | — | +15.0% |
| SG&A Expense | $17.9M | — | +46.0% |
| Operating Income | -$32.2M | — | -81.7% |
| Interest Expense | $47K | — | +67.9% |
| Pre-tax Income | -$30.0M | — | -90.7% |
| Income Tax | $16K | — | +128.6% |
| Net Income | -$30.0M | — | -90.7% |
| EPS (Basic) | -$0.29 | — | -61.1% |
| EPS (Diluted) | -$0.29 | — | -61.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.6M | -40.8% | +3.7% |
| Short-term Investments | $159.6M | +38.0% | +39.2% |
| Accounts Receivable | $13.0M | -19.6% | +18.7% |
| Current Assets | $258.2M | -3.6% | +25.1% |
| Total Assets | $325.4M | -2.6% | +19.1% |
| Current Liabilities | $39.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.5M | — | -25.1% |
| Capital Expenditures | $3.2M | — | +27.1% |
| Investing Cash Flow | -$46.0M | — | -104.1% |
| Financing Cash Flow | $17.8M | — | -11.2% |
| Free Cash Flow | -$25.7M | — | -25.4% |
| +30.6% |
| Total Liabilities | $70.6M | -3.2% | +7.1% |
| Stockholders' Equity | $254.8M | -2.5% | +22.9% |